Bowel Interest Group
  • HOME
  • ABOUT
    • MEET THE BOARD
    • CONTACT
  • WEBINARS
  • NEWS
  • RESOURCES
  • SUBSCRIBE
Select Page

News

Join our mailing list to receive our quarterly email newsletter with news, updates and events in bowel management.

SUBSCRIBE
  • All
  • Cancer
  • Coeliac Disease
  • Constipation
  • Incontinence
  • IBS
  • Inflammatory Bowel Disease
  • Paediatrics
Lilly reports positive data from its ulcerative colitis phase 3 trial

Lilly reports positive data from its ulcerative colitis phase 3 trial

April 12, 2021
Pembrolizumab added to NHSE COVID interim treatment list for colorectal cancer

Pembrolizumab added to NHSE COVID interim treatment list for colorectal cancer

April 6, 2021
NICE recommends andexanet alfa (ONDEXXYA®▼) for uncontrolled bleeds in the gastrointestinal tract

NICE recommends andexanet alfa (ONDEXXYA®▼) for uncontrolled bleeds in the gastrointestinal tract

April 6, 2021
GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient (dMMR) solid cancers

GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient (dMMR) solid cancers

January 18, 2021
New data show positive association between Remsima® SC pre-dose level with efficacy outcomes

New data show positive association between Remsima® SC pre-dose level with efficacy outcomes

October 14, 2020
Interim Results Released from Phase 2 Study on TREMFYA®▼ (guselkumab) in Patients with Crohn’s Disease

Interim Results Released from Phase 2 Study on TREMFYA®▼ (guselkumab) in Patients with Crohn’s Disease

October 14, 2020
Sandoz announces positive NICE recommendation for Rizmoic® (naldemedine) for OIC.

Sandoz announces positive NICE recommendation for Rizmoic® (naldemedine) for OIC.

September 30, 2020
Treatment for men with enlarged prostate is recommended by NICE for NHS adoption

Treatment for men with enlarged prostate is recommended by NICE for NHS adoption

September 11, 2020
Roche provide update on phase III studies of etrolizumab in people with ulcerative colitis

Roche provide update on phase III studies of etrolizumab in people with ulcerative colitis

August 10, 2020
European Commission grants marketing authorisation for Remsima® SC in Crohn’s disease & ulcerative colitis.

European Commission grants marketing authorisation for Remsima® SC in Crohn’s disease & ulcerative colitis.

July 27, 2020
New study into link between IBD and colorectal cancers

New study into link between IBD and colorectal cancers

July 22, 2020
The BSG issues interim guidance for diagnosing coeliac disease without biopsy

The BSG issues interim guidance for diagnosing coeliac disease without biopsy

July 13, 2020
  • 4
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 5

Gold Supporters

Silver Supporters

Supporters fund meetings of the expert group and pay for the services of E4H to provide secretariat support to the group. Supporters have no editorial control over the content of expert group materials except for reviewing the materials to ensure compliance with industry codes of ethical conduct.

Website owned and developed by E4H
Privacy Policy | Terms & Conditions

This site uses cookies: Find out more.